# Republic Airways Holdings Inc.: financial statements, quarterly

RJET · Nasdaq · CIK 810332 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rjet.md) · [Financials](/companies/rjet/financials.md) · [Filings](/companies/rjet/filings.md) · [Insiders](/companies/rjet/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rjet/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [114 d](/filings/0001193125-25-290253.md) | [119](/filings/0001193125-25-290253.md) | [132](/filings/0000950170-25-075201.md) | [111](/filings/0000950170-25-108021.md) | [115](/filings/0001193125-25-290256.md) | [103](/filings/0001193125-25-290253.md) | [316](/filings/0001628280-26-029330.md) | [325](/filings/0001628280-26-051405.md) | [90.7](/filings/0001193125-25-290256.md) | [1,068 d](/filings/0001628280-26-019614.md) | [439](/filings/0001628280-26-029330.md) | [483](/filings/0001628280-26-051405.md) |
| Operating income | $m | [(20.2) d](/filings/0001193125-25-290253.md) | [(51.4)](/filings/0001193125-25-290253.md) | [11.6](/filings/0000950170-25-075201.md) | [(9.0)](/filings/0000950170-25-108021.md) | [(17.0)](/filings/0001193125-25-290256.md) | [(111)](/filings/0001193125-25-290253.md) | [52.9](/filings/0001628280-26-029330.md) | [54.4](/filings/0001628280-26-051405.md) | [(9.2)](/filings/0001193125-25-290256.md) | [235 d](/filings/0001628280-26-019614.md) | [54.2](/filings/0001628280-26-029330.md) | [58.7](/filings/0001628280-26-051405.md) |
| Interest expense | $m | [13.6 d](/filings/0000950170-24-007799.md) | [11.2](/filings/0000950170-24-064406.md) | [10.6](/filings/0000950170-24-074297.md) | [9.0](/filings/0000950170-25-108021.md) | [7.6](/filings/0001193125-25-290256.md) | [7.1](/filings/0001193125-25-290253.md) | [14.3](/filings/0001628280-26-029330.md) | [14.8](/filings/0001628280-26-051405.md) | [2.8](/filings/0001193125-25-290256.md) | [49.2 d](/filings/0001628280-26-019614.md) | [16.8](/filings/0001628280-26-029330.md) | [16.8](/filings/0001628280-26-051405.md) |
| Income tax | $m | [(3.0) d](/filings/0001193125-25-290253.md) | [0.9](/filings/0001193125-25-290253.md) | [0.1](/filings/0000950170-25-075201.md) | [(0.8)](/filings/0000950170-25-108021.md) | [0.4](/filings/0001193125-25-290256.md) | [(4.3)](/filings/0001193125-25-290253.md) | [9.5](/filings/0001628280-26-029330.md) | [13.3](/filings/0001628280-26-051405.md) | [2.5](/filings/0001193125-25-290256.md) | [38.8 d](/filings/0001628280-26-019614.md) | [10.7](/filings/0001628280-26-029330.md) | [12.2](/filings/0001628280-26-051405.md) |
| Net income | $m | [(28.3) d](/filings/0001193125-25-290253.md) | [(57.9)](/filings/0001193125-25-290253.md) | [11.7](/filings/0001193125-25-290256.md) | [(19.9)](/filings/0001193125-25-290256.md) | [(24.9)](/filings/0001193125-25-290256.md) | [(112)](/filings/0001193125-25-290253.md) | [27.1](/filings/0001628280-26-051405.md) | [37.4](/filings/0001628280-26-051405.md) | [(14.1)](/filings/0001193125-25-290256.md) | [128 d](/filings/0001628280-26-019614.md) | [26.9](/filings/0001628280-26-051405.md) | [31.2](/filings/0001628280-26-051405.md) |
| Diluted EPS | $ per share | not reported | [(1.41)](/filings/0001193125-25-290253.md) | [0.28](/filings/0000950170-25-075201.md) | [(0.48)](/filings/0000950170-25-108021.md) | [(0.60)](/filings/0001193125-25-290256.md) | [(2.71)](/filings/0001193125-25-290253.md) | [0.68](/filings/0001628280-26-029330.md) | [0.94](/filings/0001628280-26-051405.md) | [(0.34)](/filings/0001193125-25-290256.md) | not reported | [0.58](/filings/0001628280-26-029330.md) | [0.68](/filings/0001628280-26-051405.md) |
| Basic EPS | $ per share | not reported | [(1.41)](/filings/0001193125-25-290253.md) | [0.28](/filings/0000950170-25-075201.md) | [(0.48)](/filings/0000950170-25-108021.md) | [(0.60)](/filings/0001193125-25-290256.md) | [(2.71)](/filings/0001193125-25-290253.md) | [0.69](/filings/0001628280-26-029330.md) | [0.96](/filings/0001628280-26-051405.md) | [(0.34)](/filings/0001193125-25-290256.md) | not reported | [0.59](/filings/0001628280-26-029330.md) | [0.68](/filings/0001628280-26-051405.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.9](/filings/0001193125-25-290253.md) | [16.1](/filings/0000950170-24-064406.md) | [18.5](/filings/0000950170-24-074297.md) | [16.3](/filings/0000950170-24-114741.md) | [15.6](/filings/0001193125-25-290253.md) | [111](/filings/0001628280-26-019614.md) | [54.1](/filings/0000950170-25-075201.md) | [42.5](/filings/0000950170-25-108021.md) | [38.7](/filings/0001193125-25-290256.md) | [134](/filings/0001628280-26-051405.md) | [111](/filings/0001628280-26-029330.md) | [116](/filings/0001628280-26-051405.md) |
| Current assets | $m | [139](/filings/0001193125-25-290253.md) | [150](/filings/0000950170-24-064406.md) | [98.4](/filings/0000950170-24-074297.md) | [84.9](/filings/0000950170-24-114741.md) | [61.3](/filings/0001193125-25-290253.md) | [453](/filings/0001628280-26-019614.md) | [164](/filings/0000950170-25-075201.md) | [133](/filings/0000950170-25-108021.md) | [115](/filings/0001193125-25-290256.md) | [541](/filings/0001628280-26-051405.md) | [487](/filings/0001628280-26-029330.md) | [535](/filings/0001628280-26-051405.md) |
| Total assets | $m | [898](/filings/0001193125-25-290253.md) | [776](/filings/0000950170-24-064406.md) | [706](/filings/0000950170-24-074297.md) | [664](/filings/0000950170-24-114741.md) | [597](/filings/0001193125-25-290253.md) | [2,768](/filings/0001628280-26-019614.md) | [215](/filings/0000950170-25-075201.md) | [179](/filings/0000950170-25-108021.md) | [159](/filings/0001193125-25-290256.md) | [3,277](/filings/0001628280-26-051405.md) | [3,265](/filings/0001628280-26-029330.md) | [3,256](/filings/0001628280-26-051405.md) |
| Current liabilities | $m | [268](/filings/0001193125-25-290253.md) | [254](/filings/0000950170-24-064406.md) | [197](/filings/0000950170-24-074297.md) | [187](/filings/0000950170-24-114741.md) | [174](/filings/0001193125-25-290253.md) | [489](/filings/0001628280-26-019614.md) | [202](/filings/0000950170-25-075201.md) | [175](/filings/0000950170-25-108021.md) | [170](/filings/0001193125-25-290256.md) | [574](/filings/0001628280-26-051405.md) | [520](/filings/0001628280-26-029330.md) | [520](/filings/0001628280-26-051405.md) |
| Total liabilities | $m | [698](/filings/0001193125-25-290253.md) | [633](/filings/0000950170-24-064406.md) | [552](/filings/0000950170-24-074297.md) | [529](/filings/0000950170-24-114741.md) | [487](/filings/0001193125-25-290253.md) | [1,652](/filings/0001628280-26-019614.md) | [277](/filings/0000950170-25-075201.md) | [220](/filings/0000950170-25-108021.md) | [212](/filings/0001193125-25-290256.md) | [1,948](/filings/0001628280-26-051405.md) | [1,913](/filings/0001628280-26-029330.md) | [1,870](/filings/0001628280-26-051405.md) |
| Long-term debt | $m | [365](/filings/0001193125-25-290253.md) | [315](/filings/0000950170-24-064406.md) | [299](/filings/0000950170-24-074297.md) | [288](/filings/0000950170-24-114741.md) | [260](/filings/0001193125-25-290253.md) | [83.8](/filings/0001193125-25-290256.md) | [31.7](/filings/0000950170-25-075201.md) | [28.2](/filings/0000950170-25-108021.md) | [27.0](/filings/0001193125-25-290256.md) | [1,025](/filings/0001628280-26-019614.md) | not reported | not reported |
| Current portion of debt | $m | [164](/filings/0001193125-25-290253.md) | [157](/filings/0000950170-24-064406.md) | [94.4](/filings/0000950170-24-074297.md) | [72.8](/filings/0000950170-24-114741.md) | [50.5](/filings/0001193125-25-290253.md) | [143](/filings/0001193125-25-290256.md) | [98.6](/filings/0000950170-25-075201.md) | [84.7](/filings/0000950170-25-108021.md) | [68.0](/filings/0001193125-25-290256.md) | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [200](/filings/0001193125-25-290253.md) | [1,046](/filings/0001628280-26-019614.md) | [155](/filings/0001193125-25-290256.md) | [135](/filings/0001193125-25-290256.md) | [110](/filings/0001193125-25-290256.md) | [1,111](/filings/0001628280-26-051405.md) | [1,138](/filings/0001628280-26-051405.md) | [1,175](/filings/0001628280-26-051405.md) | [(52.6)](/filings/0001193125-25-290256.md) | [1,329](/filings/0001628280-26-051405.md) | [1,352](/filings/0001628280-26-051405.md) | [1,386](/filings/0001628280-26-051405.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.3) d](/filings/0001193125-25-290253.md) | [(7.8)](/filings/0001193125-25-290253.md) | [16.2 d](/filings/0000950170-25-075201.md) | [11.2 d](/filings/0000950170-25-108021.md) | [14.6 d](/filings/0001193125-25-290253.md) | [(11.6)](/filings/0001193125-25-290253.md) | [53.8](/filings/0001628280-26-029330.md) | [(9.4) d](/filings/0000950170-25-108021.md) | [(177) d](/filings/0001193125-25-290256.md) | [357 d](/filings/0001628280-26-019614.md) | [57.8](/filings/0001628280-26-029330.md) | [49.3 d](/filings/0001628280-26-051405.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001193125-25-290253.md) | [6.9](/filings/0001193125-25-290253.md) | [6.3 d](/filings/0000950170-25-075201.md) | [3.7 d](/filings/0000950170-25-108021.md) | [3.4 d](/filings/0001193125-25-290253.md) | [2.1](/filings/0001193125-25-290253.md) | [39.3](/filings/0001628280-26-029330.md) | [147 d](/filings/0001628280-26-051405.md) | [(182) d](/filings/0001193125-25-290256.md) | [392 d](/filings/0001628280-26-019614.md) | [93.1](/filings/0001628280-26-029330.md) | [20.5 d](/filings/0001628280-26-051405.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2023 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.9](/filings/0000950170-24-074297.md) | [40.7](/filings/0000950170-24-114741.md) | [40.9](/filings/0001193125-25-290253.md) | [41.1](/filings/0000950170-25-075201.md) | [41.2](/filings/0000950170-25-108021.md) | [41.3](/filings/0001193125-25-290256.md) | [41.3](/filings/0001193125-25-290253.md) | [39.8](/filings/0001628280-26-029330.md) | [39.9](/filings/0001628280-26-051405.md) | [41.9](/filings/0001193125-25-290256.md) | [46.1](/filings/0001628280-26-029330.md) | [46.2](/filings/0001628280-26-051405.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,819,500 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051405.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.